CANNANDA CB2 Trademark

Trademark Overview


On Friday, July 31, 2020, a trademark application was filed for CANNANDA CB2 with the United States Patent and Trademark Office. The USPTO has given the CANNANDA CB2 trademark a serial number of 90085681. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by 3D Medicine Corporation. The CANNANDA CB2 trademark is filed in the Pharmaceutical Products category with the following description:

Non-prescription pharmaceuticals for general health and well-being, pain relief, and the treatment of arthritis; non-prescription pharmaceuticals for the treatment of inflammatory diseases, nutritional supplements for animal foodstuffs; Non-prescription pharmaceuticals for pain relief; pain relief pharmaceutical preparations; non-prescription pharmaceuticals for veterinary purposes for general health and well-being, pain relief, the treatment of arthritis, inflammatory diseases, allergies, autoimmune diseases, degenerative nerve diseases and disorders, headaches, and migraines; non-prescription pharmaceutical preparations for the treatment of allergies; non-prescription pharmaceutical preparations for the treatment of autoimmune diseases; non-prescription pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; non-prescription pharmaceutical preparations fo...
cannanda cb2

General Information


Serial Number90085681
Word MarkCANNANDA CB2
Filing DateFriday, July 31, 2020
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6918851
Registration DateTuesday, December 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 8, 2022

Trademark Statements


Goods and ServicesNon-prescription pharmaceuticals for general health and well-being, pain relief, and the treatment of arthritis; non-prescription pharmaceuticals for the treatment of inflammatory diseases, nutritional supplements for animal foodstuffs; Non-prescription pharmaceuticals for pain relief; pain relief pharmaceutical preparations; non-prescription pharmaceuticals for veterinary purposes for general health and well-being, pain relief, the treatment of arthritis, inflammatory diseases, allergies, autoimmune diseases, degenerative nerve diseases and disorders, headaches, and migraines; non-prescription pharmaceutical preparations for the treatment of allergies; non-prescription pharmaceutical preparations for the treatment of autoimmune diseases; non-prescription pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; non-prescription pharmaceutical preparations for the treatment of headaches; non-prescription pharmaceutical preparations for the treatment of migraine; non-prescription pharmaceutical preparations that target and support the endocannabinoid system; all of the aforementioned goods either containing no cannabis or containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol [THC] concentration of not more than 0.3 percent on a dry weight basis and no CBD
Pseudo MarkCANNANDA CB TWO
Disclaimer with Predetermined Text"CB2"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 31, 2020
Primary Code005
First Use Anywhere DateSunday, February 4, 2018
First Use In Commerce DateWednesday, June 6, 2018

Trademark Owner History


Party Name3D Medicine Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewmarket, Ontario L3X1A3
CA

Party Name3D Medicine Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewmarket, Ontario L3X1A3
CA

Party Name3D Medicine Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewmarket, Ontario L3X1A3
CA

Trademark Events


Event DateEvent Description
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, November 2, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 1, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 18, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, October 3, 2022USE AMENDMENT FILED
Monday, October 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 3, 2022TEAS STATEMENT OF USE RECEIVED
Friday, August 19, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 19, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 19, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 3, 2022EXAMINER'S AMENDMENT ENTERED
Monday, January 3, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 3, 2022EXAMINERS AMENDMENT E-MAILED
Monday, January 3, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, July 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 2, 2021NON-FINAL ACTION E-MAILED
Friday, July 2, 2021NON-FINAL ACTION WRITTEN
Tuesday, June 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 8, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 8, 2020NON-FINAL ACTION WRITTEN
Monday, December 7, 2020ASSIGNED TO EXAMINER
Friday, November 27, 2020ASSIGNED TO EXAMINER
Thursday, November 19, 2020ASSIGNED TO EXAMINER
Monday, August 31, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 4, 2020NEW APPLICATION ENTERED IN TRAM